Does TUCATINIB Cause Second primary malignancy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with TUCATINIB (TUKYSA). This represents 0.1% of all adverse event reports for TUCATINIB.
5
Reports of Second primary malignancy with TUCATINIB
0.1%
of all TUCATINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From TUCATINIB?
Of the 5 reports.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which TUCATINIB Alternatives Have Lower Second primary malignancy Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI